These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31394151)

  • 1. Letter to the editor regarding the article "Is a combination of assays really needed for non-animal prediction of skin sensitization potential? Performance of the GARD™ (Genomic Allergen Rapid Detection) assay in comparison with OECD guideline assays alone and in combination.".
    Forreryd A; Johansson H; Lindberg T; Zeller KS; Lindstedt M
    Regul Toxicol Pharmacol; 2019 Oct; 107():104439. PubMed ID: 31394151
    [No Abstract]   [Full Text] [Related]  

  • 2. Is a combination of assays really needed for non-animal prediction of skin sensitization potential? Performance of the GARD™ (Genomic Allergen Rapid Detection) assay in comparison with OECD guideline assays alone and in combination.
    Roberts DW
    Regul Toxicol Pharmacol; 2018 Oct; 98():155-160. PubMed ID: 30048705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to the comments of Natsch and Landsiedel on my paper "Is a combination of assays really needed for non-animal prediction of skin sensitization potential? Performance of the GARD (genomic allergen rapid detection) assay in comparison with OECD guideline assays alone and in combination.".
    Roberts DW
    Regul Toxicol Pharmacol; 2019 Mar; 102():95-97. PubMed ID: 30629968
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to the editor regarding the article by Roberts, 2018.
    Natsch A; Landsiedel R
    Regul Toxicol Pharmacol; 2019 Mar; 102():115-116. PubMed ID: 30629971
    [No Abstract]   [Full Text] [Related]  

  • 5. Validation of the GARD™skin Assay for Assessment of Chemical Skin Sensitizers: Ring Trial Results of Predictive Performance and Reproducibility.
    Johansson H; Gradin R; Johansson A; Adriaens E; Edwards A; Zuckerstätter V; Jerre A; Burleson F; Gehrke H; Roggen EL
    Toxicol Sci; 2019 Aug; 170(2):374-381. PubMed ID: 31099396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin Sensitization Testing-What's Next?
    Grundström G; Borrebaeck CAK
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30720708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated decision strategies for skin sensitization hazard.
    Strickland J; Zang Q; Kleinstreuer N; Paris M; Lehmann DM; Choksi N; Matheson J; Jacobs A; Lowit A; Allen D; Casey W
    J Appl Toxicol; 2016 Sep; 36(9):1150-62. PubMed ID: 26851134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards AOP application--implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization.
    Patlewicz G; Kuseva C; Kesova A; Popova I; Zhechev T; Pavlov T; Roberts DW; Mekenyan O
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):529-45. PubMed ID: 24928565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of androgen receptor agonistic/antagonistic effects on 25 chemicals in household applicants by OECD in vitro stably transfected transcriptional activation assays.
    Lee HS; Park EJ; Han S; Oh GY; Kang HS; Suh JH; Shin MK; Oh HS; Hwang MS; Moon G; Koh YH; Park Y; Hong JH; Koo YE
    Chemosphere; 2018 Jan; 191():589-596. PubMed ID: 29073568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sub-categorisation of skin corrosive chemicals by the EpiSkin™ reconstructed human epidermis skin corrosion test method according to UN GHS: revision of OECD Test Guideline 431.
    Alépée N; Grandidier MH; Cotovio J;
    Toxicol In Vitro; 2014 Mar; 28(2):131-45. PubMed ID: 24211528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Answer to the letter to the editor on "Environmental Phillips Curve: OECD and Asian NICs Perspective".
    Kashem MA; Rahman MM
    Environ Sci Pollut Res Int; 2020 Dec; 27(34):43412-43413. PubMed ID: 33001395
    [No Abstract]   [Full Text] [Related]  

  • 12. In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds.
    Kreiling R; Gehrke H; Broschard TH; Dreeßen B; Eigler D; Hart D; Höpflinger V; Kleber M; Kupny J; Li Q; Ungeheuer P; Sauer UG
    Regul Toxicol Pharmacol; 2017 Nov; 90():262-276. PubMed ID: 28958912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer models versus reality: how well do in silico models currently predict the sensitization potential of a substance.
    Teubner W; Mehling A; Schuster PX; Guth K; Worth A; Burton J; van Ravenzwaay B; Landsiedel R
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):468-85. PubMed ID: 24090701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro OECD test methods applied to screen the estrogenic effect of chemicals, used in Korea.
    Lee HS; Park EJ; Han S; Oh GY; Kim MH; Kang HS; Suh JH; Oh JH; Lee KS; Hwang MS; Moon G; Hong JH; Hwang IG
    Food Chem Toxicol; 2016 Sep; 95():121-7. PubMed ID: 27317829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putting the parts together: combining in vitro methods to test for skin sensitizing potentials.
    Bauch C; Kolle SN; Ramirez T; Eltze T; Fabian E; Mehling A; Teubner W; van Ravenzwaay B; Landsiedel R
    Regul Toxicol Pharmacol; 2012 Aug; 63(3):489-504. PubMed ID: 22659254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative assessment of 24-hr primary skin irritation test and human patch test data with in vitro skin irritation tests according to OECD Test Guideline 439 (for quasi-drugs in Japan).
    Sugiyama M; Akita M; Alépée N; Fujishiro M; Hagino S; Handa Y; Ikeda H; Imai N; Jitsukawa S; Katoh M; Kurihara K; Kyotani D; Nomura S; Okamoto Y; Okumura H; Omori T; Sugibayashi K; Todo H; Toyoda A; Ohno Y
    J Toxicol Sci; 2018; 43(12):751-768. PubMed ID: 30518713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fibrin-based dermal-epidermal organotypic cultures for in vitro skin corrosion and irritation testing of chemicals according to OECD TG 431 and 439.
    Morales M; Pérez D; Correa L; Restrepo L
    Toxicol In Vitro; 2016 Oct; 36():89-96. PubMed ID: 27448499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting skin sensitizers with confidence - Using conformal prediction to determine applicability domain of GARD.
    Forreryd A; Norinder U; Lindberg T; Lindstedt M
    Toxicol In Vitro; 2018 Apr; 48():179-187. PubMed ID: 29374571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of Genomic Allergen Rapid Detection (GARD) assays to predict the respiratory and skin sensitising potential of e-liquids.
    Stevenson M; Czekala L; Simms L; Tschierske N; Larne O; Walele T
    Regul Toxicol Pharmacol; 2019 Apr; 103():158-165. PubMed ID: 30629970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic allergen rapid detection in-house validation--a proof of concept.
    Johansson H; Rydnert F; Kühnl J; Schepky A; Borrebaeck C; Lindstedt M
    Toxicol Sci; 2014 Jun; 139(2):362-70. PubMed ID: 24675087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.